Arbutus Biopharma's market cap is currently $845.39M. The company's EPS TTM is $0.01; its P/E ratio is ―; Arbutus Biopharma is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
